Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial

Results of the glucose-lowering effect of WelChol study (GLOWS): A randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes

Clinical Therapeutics ◽

10.1016/j.clinthera.2007.01.003 ◽

2007 ◽

Vol 29 (1) ◽

pp. 74-83 ◽

Cited By ~ 162

Author(s):

Franklin J. Zieve ◽

Marcia F. Kalin ◽

Sherwyn L. Schwartz ◽

Michael R. Jones ◽

William L. Bailey

Keyword(s):

Type 2 Diabetes ◽

Pilot Study ◽

Glycemic Control ◽

Double Blind ◽

Glucose Lowering ◽

Double Blind Placebo ◽

Lowering Effect ◽

Glucose Lowering Effect

719-P: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Glucose-Lowering Effect of Green Jackfruit Flour in Type 2 Diabetes Mellitus Patients

Diabetes ◽

10.2337/db20-719-p ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 719-P

Author(s):

JAMES JOSEPH ◽

A. GOPAL RAO ◽

SUNIL NAYAK

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Controlled Study ◽

Double Blind ◽

Glucose Lowering ◽

Double Blind Placebo ◽

Lowering Effect ◽

Glucose Lowering Effect

The Effect of n-3 Polyunsaturated Fatty Acids Supplementation on Serum Irisin in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

International Journal of Endocrinology and Metabolism ◽

10.5812/ijem.40614 ◽

2017 ◽

Vol 15 (1) ◽

Cited By ~ 13

Author(s):

Samaneh Ansari ◽

Mahmoud Djalali ◽

Niyaz Mohammadzadeh Honarvar ◽

Maryam Mazaherioun ◽

Mahnaz Zarei ◽

...

Keyword(s):

Type 2 Diabetes ◽

Fatty Acids ◽

Polyunsaturated Fatty Acids ◽

Controlled Trial ◽

Double Blind ◽

Faculty Opinions recommendation of Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.735542506.793559665 ◽

2019 ◽

Author(s):

Carmine Zoccali ◽

Davide Bolignano

Keyword(s):

Type 2 Diabetes ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Glycaemic Control ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Lowering Effect

Using ginger supplement in adjunct with non-surgical periodontal therapy improves metabolic and periodontal parameters in patients with type 2 diabetes mellitus and chronic periodontitis: A double-blind, placebo-controlled trial

Journal of Herbal Medicine ◽

10.1016/j.hermed.2019.100315 ◽

2020 ◽

Vol 20 ◽

pp. 100315

Author(s):

Hasan Gholinezhad ◽

Hadi Bazyar ◽

Homeira Rashidi ◽

Parvin Salehi ◽

Mohammad Hosein Haghighi-zadeh ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Chronic Periodontitis ◽

Controlled Trial ◽

Periodontal Therapy ◽

Double Blind ◽

Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)

BMJ ◽

10.1136/bmj.328.7441.686-b ◽

2004 ◽

Vol 328 (7441) ◽

pp. 686.3

Keyword(s):

Type 2 Diabetes ◽

Low Dose ◽

Controlled Trial ◽

Urinary Albumin ◽

Double Blind ◽

Double Blind Placebo ◽

Renal Outcomes

Efficacy and Tolerability of Linagliptin Added to a Sulfonylurea Regimen in Patients With Inadequately Controlled Type 2 Diabetes Mellitus: An 18-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2012.07.008 ◽

2012 ◽

Vol 34 (9) ◽

pp. 1909-1919.e15 ◽

Cited By ~ 37

Author(s):

Andrew J. Lewin ◽

Lisa Arvay ◽

Dacheng Liu ◽

Sanjay Patel ◽

Maximilian von Eynatten ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Controlled Trial ◽

Double Blind ◽

The effects of vitamin D2 or D3supplementation on glycaemic control and related metabolic parameters in people at risk of type 2 diabetes: protocol of a randomised double-blind placebo-controlled trial

BMC Public Health ◽

10.1186/1471-2458-13-999 ◽

2013 ◽

Vol 13 (1) ◽

Cited By ~ 3

Author(s):

Ravi K Menon ◽

Anna P Rickard ◽

Nasima Mannan ◽

Peter M Timms ◽

Stephen J Sharp ◽

...

Keyword(s):

Type 2 Diabetes ◽

At Risk ◽

Glycaemic Control ◽

Controlled Trial ◽

Metabolic Parameters ◽

Vitamin D2 ◽

Double Blind ◽

Treatment with omega-3 polyunsaturated fatty acids does not improve endothelial function in patients with type 2 diabetes and very high cardiovascular risk: A randomized, double-blind, placebo-controlled study (Omega-FMD)

Atherosclerosis ◽

10.1016/j.atherosclerosis.2018.02.030 ◽

2018 ◽

Vol 271 ◽

pp. 148-155 ◽

Cited By ~ 12

Author(s):

Aleksander Siniarski ◽

Maciej Haberka ◽

Magdalena Mostowik ◽

Renata Gołębiowska-Wiatrak ◽

Małgorzata Poręba ◽

...

Keyword(s):

Type 2 Diabetes ◽

Fatty Acids ◽

Cardiovascular Risk ◽

Controlled Study ◽

Omega 3 ◽

High Cardiovascular Risk ◽

Double Blind ◽

Double Blind Placebo ◽

Very High

The Effects of Choline and Magnesium Co-Supplementation on Metabolic Parameters, Inflammation, and Endothelial Dysfunction in Patients With Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Trial

Journal of the American College of Nutrition ◽

10.1080/07315724.2019.1599745 ◽

2019 ◽

Vol 38 (8) ◽

pp. 714-721 ◽

Cited By ~ 7

Author(s):

Samaneh Rashvand ◽

Majid Mobasseri ◽

Ali Tarighat-Esfanjani

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Endothelial Dysfunction ◽

Controlled Trial ◽

Metabolic Parameters ◽

Double Blind ◽